Mannatech Reports Q1 2025 Financials: Net Sales Down 9.6%, Net Loss of $1.5 Million, EPS at -$0.80

Reuters
14 May
Mannatech Reports Q1 2025 Financials: Net Sales Down 9.6%, Net Loss of $1.5 Million, EPS at -$0.80

Mannatech, Incorporated $(MTEX)$, a global health and wellness company, announced its financial results for the first quarter of 2025. The company reported net sales of $26.6 million for the quarter ending March 31, 2025, reflecting a 9.6% decrease compared to $29.4 million in the same period in 2024. This decline was attributed to slowing demand in Asia due to weakened economic conditions. On a constant dollar basis, net sales decreased by $1.6 million, or 5.4%, while unfavorable foreign exchange led to a $1.2 million decrease in GAAP net sales. Mannatech reported a net loss of $1.5 million for the first quarter of 2025, contrasting with a net income of $1.2 million for the same period in the previous year. The company's cash and cash equivalents decreased by 18.2%, or $2.1 million, to $9.3 million as of March 31, 2025, from $11.4 million as of December 31, 2024. The number of new and continuing independent associate and preferred customer positions in Mannatech's network was approximately 129,000 as of March 31, 2025, compared to 143,000 in the same period of 2024, marking a 13.9% decrease in recruitment. Management noted that changes in current trade policies could impact the company's cost structure and profitability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mannatech Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001056358-25-000049), on May 13, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10